Anti-CD20 therapy for the treatment of chronic Graft Versus Host Disease

Completed

• Conditions: Chronic Graft Versus Host Disease (cGVHD); Injury, Occupational Diseases, Poisoning; Failure and rejection of transplanted organs

• Registration Number: ISRCTN43525354
• Lead Sponsor: niversity Medical Center Utrecht (UMCU) (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-10-12
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Aged over 18 years
2. Steroid refractory chronic GVHD, including skin localisation
3. No other treatment apart from steroids and when applicable standard GVHD prevention

Exclusion Criteria

1. Relapse with a life expectancy of less than six months
2. Severe infections

Study & Design

• Study Type: Interventional
• Study Design: Not specified